Corticotropin-releasing hormone analogs and their uses

Details Corticotropin-releasing hormone analogs and their uses Corticotropin-releasing hormone analogs and their uses

2007-10-23

2007-10-23

Saoud, Christine J. (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S009100, C530S300000, C530S317000, C530S324000, C930S021000, C930S270000

Reexamination Certificate

active

11006296

ABSTRACT:
This invention provides members of the corticiotropin-releasing hormone superfamily and peptide analogs thereof wherein the 38thamino acid from the N-terminus is D-Nle, i.e. [D-Nle38]-CRH peptide. The peptide analogs can be used to treat proliferative disorders of the skin such as melanoma.

REFERENCES:
patent: 4677191 (1987-06-01), Tanaka et al.
patent: 4728721 (1988-03-01), Yamamoto et al.
patent: 4801612 (1989-01-01), Wei et al.
patent: 5116868 (1992-05-01), Chen et al.
patent: 5137871 (1992-08-01), Wei
patent: 5480869 (1996-01-01), Wei et al.
patent: 5777073 (1998-07-01), Rivier
patent: 5824771 (1998-10-01), Rivier
patent: 5844074 (1998-12-01), Rivier
patent: 5869450 (1999-02-01), Wei et al.
patent: 6319900 (2001-11-01), Wei et al.
patent: 6849600 (2005-02-01), Wei et al.
Slominski et al. Corticotropin releasing hormone and the skin. Frontiers in Biosci. 11: 2230-2248, Sep. 1, 2006.
Beyermann et al. A Single-Point Slight Alteration Set as a Tool for STructure-Activity Relationship Studies of Ovine Corticotropin Releasing Factor. J. Med. Chem. 39:3324-3330, 1996.
Carlson, et al., “Inhibition of Mouse Melanoma Cell Proliferation by Corticotropin-Releasing Hormone and its Analogs,” AntiCancer Research, 21: 1173-1180 (2001).
Dautzenberg and Hauger, “The CRF peptide family and their receptors: yet more partners discovered,” Trends in Pharm. Sci., vol. 23, 2002, pp. 71-77.
Gulyas et al. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl. Acad. Sci. USA 92: 10575-10579, Nov. 1995.
Koerber et al., “Constrained Corticotropin-Releasing Factor (CRF) Agonists and Antagonists with i-(i+3) Glu-Xaa-pXbb-Lys Bridges,” J. Med. Chem., vol. 41, 1998, pp. 5002-5011.
Komreich et al., “Alanine Series of ovine Corticotropin Releasing Factor (oCRF): A Structure-Activity Relationshiop Study,” J. Med. Chem., vol. 35, 1992, pp. 1870-1876.
Rivier et al. Single Point D-Substituted Corticotropin-Releasing Factor Analogues: Effects on Potency and Physicochemical characteristics. J. Med. Chem. 36: 2851-2859, 1993.
Slominski et al., “Characterization of corticotropin-releasing hormone (CRH) in human skin,” J. Clin. Endocrin. Metab., vol. 83, 1998, pp. 1020-1024.
Slominski et al., “Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients” Hum. Pathol., vol. 30, 1999, pp. 208-215.
Slominski et al., “Proopiomelanocortin, corticotropin releasing hormone and corticotropin releasing hormone receptor genes are expressed in human skin,” FEBS Letters, vol. 374, 1999, pp. 113-116.
Stein, J.H., editor, Internal Medicine, Chapter 216, “Psoriasis,” 1998, pp. 1300-1302.
Theohardies et al., “Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explaination for its proinflammatory effects,” Endocrinology, vol. 139, 1998, pp. 403-413.
Tjuvajev et al., “Anti-Neoplastic Properties of Human Corticotropin releasing Factor: Involvement of the Nitric Oxide Pathway,” In Vivo, vol. 12, 1998, pp. 1-10.
Wei and Thomas, “Correlation of Neuroendocrine and Anti-Edema Activites of Alanine-Corticotropin-Releasing Factor Analogs,” European Journal of Pharmacology, vol. 263, 1994, pp. 319-321.
Wei et al., “D-Amino Acid-Substituted Analogs of Corticotropin-Releasing Hormone (CRH) and Urocortin with Selective Agonist Activity at CRH.sub.1 and CRH.sub.2.beta. Receptors,” Peptides, vol. 19, 1998, pp. 1183-1190.

Affiliated with

Also associated with

Rating

Corticotropin-releasing hormone analogs and their uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Corticotropin-releasing hormone analogs and their uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Corticotropin-releasing hormone analogs and their uses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3893230